iodopravadoline

Known as: 1-(2-(morpholin-4-yl)ethyl)-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole, 6-iodopravadoline, 2-methyl-3-(4-methoxybenzoyl)-6-iodo-1-(2-morpholinoethyl)-1H-indole 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2014
0119952014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Cannabinoids suppress neuropathic pain through activation of cannabinoid CB1 and/or CB2 receptors; however, unwanted CB1-mediated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
This study aimed at providing an insight on the possible role of cannabinoid (CB) type 2 receptors (CB2R) and cGMP pathway in the… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Migraine is a common and disabling neurological disorder that involves activation or the perception of activation of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
1995
1995
AM630 (iodopravadoline), a novel aminoalkylindole, has been found to attenuate the ability of a number of cannabinoids to inhibit… (More)
Is this relevant?